NCT06617442

Brief Summary

Pulmonary vein isolation (PVI) is the most effective means of maintaining sinus rhythm in atrial fibrillation (AF), while a widely used approach to PVI is point-by-point radiofrequency (RF) catheter ablation. High power short duration (HPSD) and very high power short duration e.g., 90W and 4 sec) are increasingly popular technologies, featuring higher power and shorter application durations compared to previous methods. vHPSD offers similar efficacy to HPSD, while further reducing procedure times. Atrioesophageal fistula (AEF) is a rare but deadly complication of PVI, while endoscopically detected esophageal lesions are surrogate markers for the risk of AEF. Furthermore, thermal complications include vagal lesions leading to gastroparesis. While there is considerable data on the thermal safety of HPSD technology, most studies of vHPSD focus on efficacy and a direct comparison in terms of esophageal safety is lacking. In this randomized, single-center study, we aim to compare the thermal safety of vHPSD to HPSD. Furthermore, we aimed to determine the anatomical and biophysical factors that predict thermal injury. Patients undergoing their first PVI for AF are randomized to either HPSD or vHPSD power setting. The primary endpoint of the study is the composite of esophageal mucosal lesion and gastroparesis, as assessed at the post-procedural endoscopy within 15 days after the PVI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 16, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 4, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 25, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 27, 2024

Completed
Last Updated

September 27, 2024

Status Verified

September 1, 2024

Enrollment Period

2.4 years

First QC Date

September 25, 2024

Last Update Submit

September 25, 2024

Conditions

Keywords

Pulmonary Vein IsolationPVIHPSDHigh Power Short DurationEsophageal injury

Outcome Measures

Primary Outcomes (1)

  • Thermal injury detected during post-procedural endoscopy

    Composite of esophageal ulcer or erosion and gastric hypomotility.

    Post-procedural endoscopy was performed within 15 days after the procedure.

Study Arms (2)

90W

EXPERIMENTAL

Pulmonary vein isolation performed using very-high power short duration applications (90-watt applications lasting 4 seconds).

Procedure: Pulmonary vein isolation

50W

ACTIVE COMPARATOR

Pulmonary vein isolation performed using high power short duration applications (50-watt applications guided by ablation index).

Procedure: Pulmonary vein isolation

Interventions

First pulmonary vein isolation performed for atrial fibrillation.

50W90W

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • \- Patients with paroxysmal or persistent atrial fibrillation undergoing their first pulmonary vein isolation procedure

You may not qualify if:

  • Additional ablation performed outside PVI
  • Contraindications to postoperative upper endoscopy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Semmelweis University Heart and Vascular Center

Budapest, Hungary, 1122, Hungary

Location

MeSH Terms

Conditions

Atrial FibrillationEsophageal Perforation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, open label
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 25, 2024

First Posted

September 27, 2024

Study Start

February 16, 2022

Primary Completion

July 4, 2024

Study Completion

July 4, 2024

Last Updated

September 27, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations